These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21510942)

  • 1. Receptor mediated endocytosis 8 is a novel PI(3)P binding protein regulated by myotubularin-related 2.
    Xhabija B; Taylor GS; Fujibayashi A; Sekiguchi K; Vacratsis PO
    FEBS Lett; 2011 Jun; 585(12):1722-8. PubMed ID: 21510942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated Endocytosis 8 Utilizes an N-terminal Phosphoinositide-binding Motif to Regulate Endosomal Clathrin Dynamics.
    Xhabija B; Vacratsis PO
    J Biol Chem; 2015 Aug; 290(35):21676-89. PubMed ID: 26134565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential phosphorylation of the phosphoinositide 3-phosphatase MTMR2 regulates its association with early endosomal subtypes.
    Franklin NE; Bonham CA; Xhabija B; Vacratsis PO
    J Cell Sci; 2013 Mar; 126(Pt 6):1333-44. PubMed ID: 23378027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphoinositide 3-phosphatase MTMR2 interacts with PSD-95 and maintains excitatory synapses by modulating endosomal traffic.
    Lee HW; Kim Y; Han K; Kim H; Kim E
    J Neurosci; 2010 Apr; 30(16):5508-18. PubMed ID: 20410104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosomal targeting of the phosphoinositide 3-phosphatase MTMR2 is regulated by an N-terminal phosphorylation site.
    Franklin NE; Taylor GS; Vacratsis PO
    J Biol Chem; 2011 May; 286(18):15841-53. PubMed ID: 21372139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module.
    Berger P; Schaffitzel C; Berger I; Ban N; Suter U
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12177-82. PubMed ID: 14530412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking.
    Cao C; Backer JM; Laporte J; Bedrick EJ; Wandinger-Ness A
    Mol Biol Cell; 2008 Aug; 19(8):3334-46. PubMed ID: 18524850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.
    Kim SA; Taylor GS; Torgersen KM; Dixon JE
    J Biol Chem; 2002 Feb; 277(6):4526-31. PubMed ID: 11733541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotubularin phosphoinositide phosphatases in human diseases.
    Amoasii L; Hnia K; Laporte J
    Curr Top Microbiol Immunol; 2012; 362():209-33. PubMed ID: 23086420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phosphoinositide conversion mechanism for exit from endosomes.
    Ketel K; Krauss M; Nicot AS; Puchkov D; Wieffer M; Müller R; Subramanian D; Schultz C; Laporte J; Haucke V
    Nature; 2016 Jan; 529(7586):408-12. PubMed ID: 26760201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotubularin related protein-2 and its phospholipid substrate PIP
    Narayanan P; Hütte M; Kudryasheva G; Taberner FJ; Lechner SG; Rehfeldt F; Gomez-Varela D; Schmidt M
    Elife; 2018 Mar; 7():. PubMed ID: 29521261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease.
    Robinson FL; Dixon JE
    J Biol Chem; 2005 Sep; 280(36):31699-707. PubMed ID: 15998640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1.
    Berger P; Bonneick S; Willi S; Wymann M; Suter U
    Hum Mol Genet; 2002 Jun; 11(13):1569-79. PubMed ID: 12045210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes.
    Cao C; Laporte J; Backer JM; Wandinger-Ness A; Stein MP
    Traffic; 2007 Aug; 8(8):1052-67. PubMed ID: 17651088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CMT4B disease-causing proteins MTMR2 and MTMR13/SBF2 regulate AKT signalling.
    Berger P; Tersar K; Ballmer-Hofer K; Suter U
    J Cell Mol Med; 2011 Feb; 15(2):307-15. PubMed ID: 19912440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An In Vitro Model of Charcot-Marie-Tooth Disease Type 4B2 Provides Insight Into the Roles of MTMR13 and MTMR2 in Schwann Cell Myelination.
    Robinson DC; Mammel AE; Logan AM; Larson AA; Schmidt EJ; Condon AF; Robinson FL
    ASN Neuro; 2018; 10():1759091418803282. PubMed ID: 30419760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1.
    Srivastava S; Li Z; Lin L; Liu G; Ko K; Coetzee WA; Skolnik EY
    Mol Cell Biol; 2005 May; 25(9):3630-8. PubMed ID: 15831468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2.
    Berger P; Berger I; Schaffitzel C; Tersar K; Volkmer B; Suter U
    Hum Mol Genet; 2006 Feb; 15(4):569-79. PubMed ID: 16399794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role for the myotubularin-related phosphatase Ymr1p and the synaptojanin-like phosphatases Sjl2p and Sjl3p in regulation of phosphatidylinositol 3-phosphate in yeast.
    Parrish WR; Stefan CJ; Emr SD
    Mol Biol Cell; 2004 Aug; 15(8):3567-79. PubMed ID: 15169871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport.
    Chaussade C; Pirola L; Bonnafous S; Blondeau F; Brenz-Verca S; Tronchère H; Portis F; Rusconi S; Payrastre B; Laporte J; Van Obberghen E
    Mol Endocrinol; 2003 Dec; 17(12):2448-60. PubMed ID: 14500759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.